Wilderness & environmental medicine
-
Wilderness Environ Med · Jan 2000
Subterranean medicine: an inquiry into underground medical treatment protocols in cave rescue situations in national parks in the United States.
Caving and spelunking have become increasingly popular over the years, with hundreds of thousands of amateur spelunkers across the country visiting caves. National parks in the United States offer hundreds of caves for all levels of spelunkers and, in fact, many national parks boast caves as either their main or major attraction. In an effort to increase visitor safety and establish subterranean medical treatment protocols, we began an investigation into cave rescue, medical protocols, previously published recommendations concerning cave safety, and visitor and rescue statistics in the national parks. ⋯ The vast number of those calls were for minor injuries. Second, no strict evidence-based treatment protocols for underground injuries exist, probably because they are not feasible. A caving incident database for the national parks would facilitate suggestions for preventative measures for the minor injuries and would help catalog the creative solutions for the rare serious subterranean medical incident.
-
Wilderness Environ Med · Jan 2000
Irukandji and Chironex fleckeri jellyfish envenomation in tropical Australia.
To compare the temporal distribution of Irukandji and Chironex fleckeri stings, the demographics of victims, the prevailing physical conditions at the time of a sting, and the prevalence of unsuitable first aid strategies. ⋯ This study failed to predict exact weather patterns or other contributing factors to reduce the risk of stings to an acceptable level, but did identify several factors that increase the incidence of stings. The "stinger-free" season reported on Chironex warning signs is inaccurate and should be changed to warn bathers that Chironex may be present year round, particularly in the Northern Territory.
-
Wilderness Environ Med · Jan 2000
Case ReportsExperimental use of a transportable hyperbaric chamber durable for 15 psi at 3700 meters above sea level.
A transportable hyperbaric chamber durable for 15 psi of pressure was used to treat a patient suffering from moderate acute mountain sickness at 3700 m above sea level. The symptoms were ameliorated a few minutes after pressurization in the chamber. ⋯ Since the chamber can be inflated by using compressed air from a cylinder, no strenuous work was required of the operators. This transportable chamber seems to be useful for the treatment of high-altitude disorders at around 3000 m above sea level.
-
Wilderness Environ Med · Jan 2000
Planning for an annual episodic mass gathering: emergency department and clinic utilization in Yellowstone.
Planning and providing emergency and primary care for a large transient population of visitors and employees in a national park can be problematic. Furthermore, planning for emergency and primary health care needs of visitors and itinerant workers in a wilderness area national park has not been well documented. A study was performed to analyze emergency and primary health care utilization in a national park. ⋯ Utilization analysis revealed differences between conventional mass gatherings and the mass gatherings in Yellowstone. Because of the unique conditions and populations found in a wilderness area, conventional mass gathering emergency medical service models may not be an appropriate model for planning health care in a national park. Analysis of utilization data can help plan resources for emergency and primary health care for a park population.
-
Wilderness Environ Med · Jan 1999
ReviewThe cerebral etiology of high-altitude cerebral edema and acute mountain sickness.
Despite normal cerebral oxygenation and normal global cerebral metabolism, vasogenic edema develops in humans (and sheep) who become moderately ill with AMS/ HACE during 24 hr or more of hypoxic exposure. Hypoxic cerebral vasodilatation appears to be a necessary ingredient but does not per se explain the development of brain edema. In addition to mechanical factors, a number of biochemical mediators might play a role in altering the blood-brain barrier. ⋯ The "tight fit" hypothesis proposes that individual anatomy of the craniospinal axis determines tolerance to mild brain edema and might help explain individual susceptibility; preliminary studies support this notion. Therapy for AMS and HACE is directed to reducing brain volume and stopping the BBB leak (i.e., oxygenation, diuretics, and steroids) before secondary ischemia develops. New therapies directed specifically toward the defect in BBB permeability are likely to be successful.